Conference abstracts

Personalized glycemic response based Diabefly-Pro® digital therapeutics improves dietary patterns, glycemic control and reduces postprandial hyperglycemia in real-world settings

108 individuals participated in personalised glycemic response based Diabefly pro program. After week 2 of the program, participants showed a significant reduction in AUC, iAUC-post breakfast, and TAR by 44.7%, 42.3%,and 5% respectively. The intake of calories, and carbohydrate was also significantly reduced. TIR showed significant improvement by 2.7%. In conclusion, Diabefly-Pro® program led to significant reduction in postprandial hyperglycemia while improving TIR and dietary behaviour in people with diabetes.